Phase 3 studies showed zasocitinib, a highly selective oral tyrosine kinase 2 inhibitor, provided rapid, durable skin improvement.

TEHRAN, Iran (AP) - Iran, the United States and Israel agreed to a two-week ceasefire in an 11th-hour deal that headed off ...

Deucravacitinib showed strong psoriasis control and rapid scalp clearance with mild adverse events in real-world practice.

Two Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising results. Approximately 70% of ...

What has made the biggest impact on dentistry and dental practice today? This Collection reflects the issues that really matter to practising dentists and are some of the recent hottest topics from ...

Pearson, a major UK-based education board responsible for setting international GCSE and A-Level exams in over 80 countries, ...